Invasive bladder cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Open Access
- 1 May 2009
- journal article
- review article
- Published by Elsevier BV in Annals Of Oncology
- Vol. 20 (suppl_4), iv79-iv80
- https://doi.org/10.1093/annonc/mdp136
Abstract
The crude incidence of invasive bladder cancer in the European Union is 19.5/100 000/year, the mortality is 7.9/100 000/year; 70% of patients with bladder cancer are >65 years of age.Keywords
This publication has 21 references indexed in Scilit:
- ReplyUrology, 2007
- Chemotherapy for Bladder Cancer: Treatment Guidelines for Neoadjuvant Chemotherapy, Bladder Preservation, Adjuvant Chemotherapy, and Metastatic CancerUrology, 2007
- Adjuvant chemotherapy for bladder cancerExpert Review of Anticancer Therapy, 2005
- Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder CancerJournal of Clinical Oncology, 2005
- Neoadjuvant Chemotherapy for Transitional Cell Carcinoma of the Bladder: A Systematic Review and Meta-AnalysisJournal of Urology, 2004
- Neoadjuvant Cisplatinum Based Combination Chemotherapy in Patients with Invasive Bladder Cancer: A Combined Analysis of Two Nordic StudiesEuropean Urology, 2003
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003
- BLADDER CANCER CLINICAL GUIDELINES PANEL SUMMARY REPORT ON THE MANAGEMENT OF NONMUSCLE INVASIVE BLADDER CANCER (STAGES Ta, T1 AND TIS)Journal of Urology, 1999
- The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary BladderThe American Journal of Surgical Pathology, 1998
- 25-Year Experience in the Management of Invasive Bladder Cancer by Radical CystectomyEuropean Urology, 1998